STOCK TITAN

DEXIS to Showcase Cutting-Edge Innovations at IDS 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

DEXIS, a global dental imaging technology leader, has announced its participation in the International Dental Show (IDS) 2025 in Cologne, Germany. The company will showcase several innovations within its AI-powered digital ecosystem, including:

- Imprevo: A new high-performance intraoral scanner with rebuilt hardware and AI-powered algorithm

- IS ScanFlow 2.0: Updated software featuring a new Smile Visualizer tool for treatment previews

- ORTHOPANTOMOGRAPH OP 3D EX updates with new cephalometric imaging capabilities

- Automatic Dose Control feature for the ORTHOPANTOMOGRAPH OP 3D LX

- DTX Studio Clinic enhancements including automated implant planning, 3-minute surgical template generation, and upcoming AI-driven endodontic capabilities

The company will demonstrate these technologies at Hall 11.2 K050 L069, highlighting their integration into DEXIS's comprehensive digital workflow solution that currently has over 165,000 installations worldwide.

DEXIS, leader globale nella tecnologia di imaging dentale, ha annunciato la sua partecipazione all'International Dental Show (IDS) 2025 a Colonia, Germania. L'azienda presenterà diverse innovazioni all'interno del suo ecosistema digitale potenziato dall'IA, tra cui:

- Imprevo: Un nuovo scanner intraorale ad alte prestazioni con hardware rinnovato e algoritmo potenziato dall'IA

- IS ScanFlow 2.0: Software aggiornato con un nuovo strumento Smile Visualizer per anteprime dei trattamenti

- Aggiornamenti per ORTHOPANTOMOGRAPH OP 3D EX con nuove capacità di imaging cefalometrico

- Funzione di Controllo Automatico della Dose per l'ORTHOPANTOMOGRAPH OP 3D LX

- Miglioramenti del DTX Studio Clinic che includono pianificazione automatizzata degli impianti, generazione di template chirurgici in 3 minuti e future capacità endodontiche guidate dall'IA

L'azienda dimostrerà queste tecnologie presso il Padiglione 11.2 K050 L069, evidenziando la loro integrazione nella soluzione di workflow digitale completa di DEXIS, attualmente con oltre 165.000 installazioni in tutto il mondo.

DEXIS, líder global en tecnología de imagen dental, ha anunciado su participación en el International Dental Show (IDS) 2025 en Colonia, Alemania. La empresa presentará varias innovaciones dentro de su ecosistema digital potenciado por IA, que incluyen:

- Imprevo: Un nuevo escáner intraoral de alto rendimiento con hardware renovado y algoritmo potenciado por IA

- IS ScanFlow 2.0: Software actualizado con una nueva herramienta Smile Visualizer para previsualizaciones de tratamientos

- Actualizaciones de ORTHOPANTOMOGRAPH OP 3D EX con nuevas capacidades de imagen cefalométrica

- Función de Control Automático de Dosis para el ORTHOPANTOMOGRAPH OP 3D LX

- Mejoras en DTX Studio Clinic que incluyen planificación automatizada de implantes, generación de plantillas quirúrgicas en 3 minutos y futuras capacidades endodónticas impulsadas por IA

La empresa demostrará estas tecnologías en el Pabellón 11.2 K050 L069, destacando su integración en la solución de flujo de trabajo digital integral de DEXIS, que actualmente cuenta con más de 165,000 instalaciones en todo el mundo.

DEXIS는 글로벌 치과 이미징 기술 리더로서 독일 쾰른에서 열리는 International Dental Show (IDS) 2025에 참여한다고 발표했습니다. 이 회사는 AI 기반 디지털 생태계 내 여러 혁신을 선보일 예정입니다:

- Imprevo: 하드웨어가 재구성된 고성능 구강 내 스캐너와 AI 기반 알고리즘

- IS ScanFlow 2.0: 치료 미리보기를 위한 새로운 Smile Visualizer 도구가 포함된 업데이트된 소프트웨어

- 새로운 두개골 이미징 기능을 갖춘 ORTHOPANTOMOGRAPH OP 3D EX 업데이트

- ORTHOPANTOMOGRAPH OP 3D LX의 자동 용량 제어 기능

- 자동 임플란트 계획, 3분 내 수술 템플릿 생성 및 향후 AI 기반 근관 치료 기능을 포함한 DTX Studio Clinic 개선 사항

회사는 이러한 기술을 Hall 11.2 K050 L069에서 시연하며, 현재 전 세계에 165,000개 이상의 설치가 있는 DEXIS의 포괄적인 디지털 작업 흐름 솔루션에 통합된 것을 강조할 것입니다.

DEXIS, leader mondial dans la technologie d'imagerie dentaire, a annoncé sa participation au International Dental Show (IDS) 2025 à Cologne, en Allemagne. L'entreprise présentera plusieurs innovations au sein de son écosystème numérique alimenté par l'IA, notamment :

- Imprevo : Un nouveau scanner intraoral haute performance avec un matériel reconstruit et un algorithme alimenté par l'IA

- IS ScanFlow 2.0 : Logiciel mis à jour avec un nouvel outil Smile Visualizer pour les aperçus de traitement

- Mises à jour de ORTHOPANTOMOGRAPH OP 3D EX avec de nouvelles capacités d'imagerie céphalométrique

- Fonction de Contrôle Automatique de Dose pour l'ORTHOPANTOMOGRAPH OP 3D LX

- Améliorations de DTX Studio Clinic comprenant la planification automatisée des implants, la génération de modèles chirurgicaux en 3 minutes et de futures capacités endodontiques pilotées par l'IA

L'entreprise démontrera ces technologies au Hall 11.2 K050 L069, mettant en avant leur intégration dans la solution de flux de travail numérique complète de DEXIS, qui compte actuellement plus de 165 000 installations dans le monde.

DEXIS, ein weltweit führendes Unternehmen im Bereich der zahnmedizinischen Bildgebungstechnologie, hat seine Teilnahme an der International Dental Show (IDS) 2025 in Köln, Deutschland, angekündigt. Das Unternehmen wird mehrere Innovationen innerhalb seines KI-gestützten digitalen Ökosystems präsentieren, darunter:

- Imprevo: Ein neuer Hochleistungs-Intraoralscanner mit neuem Hardware-Design und KI-gestütztem Algorithmus

- IS ScanFlow 2.0: Aktualisierte Software mit einem neuen Smile Visualizer-Tool für Behandlungsvorschauen

- Aktualisierungen des ORTHOPANTOMOGRAPH OP 3D EX mit neuen cefalometrischen Bildgebungsfunktionen

- Automatische Dosisregelung für den ORTHOPANTOMOGRAPH OP 3D LX

- Verbesserungen des DTX Studio Clinic, einschließlich automatisierter Implantatplanung, Erstellung von chirurgischen Vorlagen in 3 Minuten und zukünftigen KI-gesteuerten endodontischen Funktionen

Das Unternehmen wird diese Technologien in Halle 11.2 K050 L069 demonstrieren und dabei die Integration in die umfassende digitale Workflow-Lösung von DEXIS hervorheben, die derzeit über 165.000 Installationen weltweit aufweist.

Positive
  • Introduction of new high-performance Imprevo intraoral scanner
  • Launch of automated surgical template generation reducing procedure time to under 3 minutes
  • Integration of AI-powered features for improved diagnostic accuracy
  • Expansion of imaging capabilities with new cephalometric features
  • Implementation of Automatic Dose Control for optimized image quality
Negative
  • None.

QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / March 24, 2025 / DEXIS, the global leader in dental imaging technologies, is excited to announce its participation in the International Dental Show (IDS) 2025 in Cologne, Germany.

The company will showcase new technologies within the DEXIS digital ecosystem, an AI-powered platform that connects each step of the digital workflow, from diagnosis to delivery. The ecosystem combines AI, 2D & 3D imaging, intraoral scanning, diagnostics, and treatment planning to create one integrated solution that streamlines processes and boosts productivity.

"We're excited to give IDS attendees the very first look at some of our new technologies," says DEXIS President, Robert Befidi. "All of our innovations are designed to improve patient interactions and make dental practices more effective and efficient. We're eager to put our products into the hands of dental professionals and demonstrate the capabilities of our new technologies."

Among these innovations are some exciting updates to the DEXIS intraoral scanning portfolio. Visitors will get an exclusive first look at the company's all-new intraoral scanner under development, Imprevo. With a sleek new design, fully rebuilt hardware, and AI-powered algorithm, Imprevo will become the new high-performance flagship of the DEXIS IOS portfolio.

IS ScanFlow, the software that powers the DEXIS intraoral scanner line, will preview its newest version, IS ScanFlow 2.0, featuring a new Smile Visualizer tool. The tool will allow dental professionals to show patients a realistic preview of their smile before and after treatments, helping them to visualize and better understand treatment recommendations.

DEXIS will also unveil updates to the ORTHOPANTOMOGRAPH™ OP 3D™ EX, which will soon include cephalometric imaging capabilities. The new ceph modality, which features the company's patented ORTHOceph™ Plus design, will provide necessary protocols such as lateral and pediatric lateral projections, posterior-anterior projections and carpus imaging* - all with fast scan times and at a limited dose.

Additionally, the DEXIS 3D imaging portfolio will introduce an Automatic Dose Control feature for the ORTHOPANTOMOGRAPH™ OP 3D™ LX. The feature will measure patients' anatomy and automatically set exposure levels for optimal image quality and dose. Early adopters have reported positive feedback:

"The new Automatic Dose Control is one of the few things in life I don't have to question," says Dr. Katya Archambault of San Diego Health Center. "It offers both better and more consistent image quality. I could never argue with the results."

Also being showcased are new features within DTX Studio™ Clinic, the core software of the DEXIS digital ecosystem. Known for its comprehensive integration of all modalities of patient data, DTX Studio Clinic streamlines diagnostics, patient education, treatment planning, and surgical guide generation.

The software's new features include a suite of tools designed to streamline the implant treatment planning process. Users can now plan an implant treatment and generate an automated surgical template chairside in under 3 minutes. Additionally, the software introduces an Assisted Implant Planning module that automates initial implant positioning, and a Face Scan tool that integrates facial scans with 3D X-rays, further enhancing the planning process.

Attendees will also get the chance to preview new innovations, set to be released in future updates of DTX Studio Clinic. Among these innovations is a new, AI-driven endodontic capability, that will provide 3D visualizations of root canals, enhancing diagnostic accuracy and treatment efficiency. Additionally, updates to the focus areas detection tool will be showcased, enhancing the visualization of teeth in intraoral X-rays and detecting eight additional dental findings.

DTX Studio Clinic will also introduce a new Cloud-based solution that will allow clinicians to connect their practices and consolidate data in one place. This feature is designed to enhance collaboration and streamline workflows, ultimately improving practice efficiency and patient outcomes. These advancements showcase the future of dental technology, making DTX Studio Clinic an integral part of modern dentistry.

DEXIS invites all IDS attendees to visit Hall 11.2 K050 L069 to experience the innovations that DEXIS has to offer. Their team of experts will be ready to provide demonstrations and answer questions.

With more than 165,000 solutions in use around the world, DEXIS continues to set the standard for quality and reliability in dental imaging. For more information about DEXIS and its participation in IDS, please visit DEXIS @ IDS 2025.

About DEXIS

DEXIS is the global leader in dental imaging. We bring together the most trusted brands in 2D and 3D imaging, intraoral scanning solutions, and diagnostic software, in one connected and AI-powered ecosystem. Our innovative and award-winning technologies use smart simplicity to increase productivity and enhance diagnostic confidence. For more information, please visit DEXIS.com.

About Envista

Envista Holdings Corporation is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide array of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit  www.envistaco.com. 

DXIS01006/Rev00

*Carpus is an optional imaging program

Contact Information

Maria Penaloza
Media & Content Strategy Manager
mariap@accessnewswire.com

Michelle Cabral
Senior Marketing Director, DEXIS
michelle.cabral@envistaco.com

.

SOURCE: Envista



View the original press release on ACCESS Newswire

FAQ

What new products will DEXIS showcase at IDS 2025?

DEXIS will showcase Imprevo intraoral scanner, IS ScanFlow 2.0 with Smile Visualizer, ORTHOPANTOMOGRAPH OP 3D EX with ceph capabilities, and enhanced DTX Studio Clinic software features.

How long does it take to generate a surgical template in the new DTX Studio Clinic?

The new DTX Studio Clinic can generate an automated surgical template chairside in under 3 minutes.

What is the new Automatic Dose Control feature in ORTHOPANTOMOGRAPH OP 3D LX?

It automatically measures patient anatomy and sets optimal exposure levels for better image quality while controlling radiation dose.

What AI capabilities are coming to DTX Studio Clinic?

New AI features include endodontic capabilities for 3D root canal visualization and enhanced focus areas detection tool for identifying eight additional dental findings.

How many DEXIS solutions are currently in use globally?

DEXIS has more than 165,000 solutions in use around the world.
Envista Holdings Corp

NYSE:NVST

NVST Rankings

NVST Latest News

NVST Stock Data

2.59B
170.65M
0.87%
115.83%
4.96%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
BREA